Therapeutic Radioisotopes Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
Therapeutic Radioisotopes Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 (Updated Report Available)
ID : RI_
78062 | Date :
Jun, 2020 | Pages :
167 | Region : Global |
Publisher : RI
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The Global Therapeutic Radioisotopes Market size was xxx million USD with a CAGR xx % from 2015- 2019. It will stretch to xxx million USD in 2020 with a CAGR of xx % from 2020 - 2026.
As the report focuses on global Therapeutic Radioisotopes Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Radium-223
Lutetium-177
Iodine-131
Other In Market segmentation by applications :
Thyroid
Bone Metastasis
Lymphoma
Other
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Therapeutic Radioisotopes Market for the forecast period 2020 - 2026?
• What are the driving forces in the Therapeutic Radioisotopes Market for the forecast period 2020 - 2026?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Therapeutic Radioisotopes industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players?
Table of Contents
Global Therapeutic Radioisotopes Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Radioisotopes Consumption 2015-2026
2.1.2 Therapeutic Radioisotopes Consumption CAGR by Region
2.2 Therapeutic Radioisotopes Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Radioisotopes Consumption by Type
2.3.1 Global Therapeutic Radioisotopes Consumption Market Share by Type (2015-2019)
2.3.2 Global Therapeutic Radioisotopes Revenue and Market Share by Type (2015-2019)
2.3.3 Global Therapeutic Radioisotopes Sale Price by Type (2015-2019)
2.4 Therapeutic Radioisotopes Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Radioisotopes Consumption by Application
2.5.1 Global Therapeutic Radioisotopes Consumption Market Share by Application (2015-2019)
2.5.2 Global Therapeutic Radioisotopes Value and Market Share by Application (2015-2019)
2.5.3 Global Therapeutic Radioisotopes Sale Price by Application (2015-2019)
3 Global Therapeutic Radioisotopes by Players
3.1 Global Therapeutic Radioisotopes Sales Market Share by Players
3.1.1 Global Therapeutic Radioisotopes Sales by Players (2018-2019)
3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Players (2018-2019)
3.2 Global Therapeutic Radioisotopes Revenue Market Share by Players
3.2.1 Global Therapeutic Radioisotopes Revenue by Players (2018-2019)
3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Players (2018-2019)
3.3 Global Therapeutic Radioisotopes Sale Price by Players
3.4 Global Therapeutic Radioisotopes Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Therapeutic Radioisotopes Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Therapeutic Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Therapeutic Radioisotopes by Regions
4.1 Therapeutic Radioisotopes by Regions
4.1.1 Global Therapeutic Radioisotopes Consumption by Regions
4.1.2 Global Therapeutic Radioisotopes Value by Regions
4.2 Americas Therapeutic Radioisotopes Consumption Growth
4.3 APAC Therapeutic Radioisotopes Consumption Growth
4.4 Europe Therapeutic Radioisotopes Consumption Growth
4.5 Middle East & Africa Therapeutic Radioisotopes Consumption Growth
5 Americas
5.1 Americas Therapeutic Radioisotopes Consumption by Countries
5.1.1 Americas Therapeutic Radioisotopes Consumption by Countries (2015-2019)
5.1.2 Americas Therapeutic Radioisotopes Value by Countries (2015-2019)
5.2 Americas Therapeutic Radioisotopes Consumption by Type
5.3 Americas Therapeutic Radioisotopes Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Therapeutic Radioisotopes Consumption by Countries
6.1.1 APAC Therapeutic Radioisotopes Consumption by Countries (2015-2019)
6.1.2 APAC Therapeutic Radioisotopes Value by Countries (2015-2019)
6.2 APAC Therapeutic Radioisotopes Consumption by Type
6.3 APAC Therapeutic Radioisotopes Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Therapeutic Radioisotopes by Countries
7.1.1 Europe Therapeutic Radioisotopes Consumption by Countries (2015-2019)
7.1.2 Europe Therapeutic Radioisotopes Value by Countries (2015-2019)
7.2 Europe Therapeutic Radioisotopes Consumption by Type
7.3 Europe Therapeutic Radioisotopes Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Radioisotopes by Countries
8.1.1 Middle East & Africa Therapeutic Radioisotopes Consumption by Countries (2015-2019)
8.1.2 Middle East & Africa Therapeutic Radioisotopes Value by Countries (2015-2019)
8.2 Middle East & Africa Therapeutic Radioisotopes Consumption by Type
8.3 Middle East & Africa Therapeutic Radioisotopes Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
11 Global Therapeutic Radioisotopes Market Forecast
11.1 Global Therapeutic Radioisotopes Consumption Forecast (2020-2026)
11.2 Global Therapeutic Radioisotopes Forecast by Regions
11.2.1 Global Therapeutic Radioisotopes Forecast by Regions (2020-2026)
11.2.2 Global Therapeutic Radioisotopes Value Forecast by Regions (2020-2026)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Therapeutic Radioisotopes Forecast by Type
11.8 Global Therapeutic Radioisotopes Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Therapeutic Radioisotopes Product Offered
12.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Novartis
12.2.1 Company Details
12.2.2 Therapeutic Radioisotopes Product Offered
12.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.2.4 Main Business Overview
12.2.5 Novartis News
12.3 China Isotope & Radiation
12.3.1 Company Details
12.3.2 Therapeutic Radioisotopes Product Offered
12.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.3.4 Main Business Overview
12.3.5 China Isotope & Radiation News
12.4 Dongcheng
12.4.1 Company Details
12.4.2 Therapeutic Radioisotopes Product Offered
12.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.4.4 Main Business Overview
12.4.5 Dongcheng News
12.5 Q BioMed
12.5.1 Company Details
12.5.2 Therapeutic Radioisotopes Product Offered
12.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.5.4 Main Business Overview
12.5.5 Q BioMed News
12.6 Curium Pharmaceuticals
12.6.1 Company Details
12.6.2 Therapeutic Radioisotopes Product Offered
12.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.6.4 Main Business Overview
12.6.5 Curium Pharmaceuticals News
12.7 Jubilant DraxImage
12.7.1 Company Details
12.7.2 Therapeutic Radioisotopes Product Offered
12.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.7.4 Main Business Overview
12.7.5 Jubilant DraxImage News
12.8 Lantheus
12.8.1 Company Details
12.8.2 Therapeutic Radioisotopes Product Offered
12.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.8.4 Main Business Overview
12.8.5 Lantheus News
12.9 Spectrum Pharmaceuticals
12.9.1 Company Details
12.9.2 Therapeutic Radioisotopes Product Offered
12.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.9.4 Main Business Overview
12.9.5 Spectrum Pharmaceuticals News
12.10 Progenics Pharmaceuticals
12.10.1 Company Details
12.10.2 Therapeutic Radioisotopes Product Offered
12.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2018-2019)
12.10.4 Main Business Overview
12.10.5 Progenics Pharmaceuticals News
12.11 International Isotopes
13 Research Findings and Conclusion
Research Methodology
The Reports Insights offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Reports Insights assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Reports Insights provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
The report is pretty good as a whole. Especially, the analysis on margin and manufacturing cost is challenging to investigate in general. The team of Reports Insights provided a proper explanation to this. It helped me understand the market well, which leads to our interest in the next marketing report from Reports Insights. I would like to thank the entire team for living up to my expectations in terms of quality & value.
I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.
Privacy requested , Managing Director
Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.
Privacy requested, President
Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.
